[1]
2017. Trial of Immunotherapy in HIV Patients: Our Experience with the Immuno-Modulator Dithiodinicotinic Acid (CPDS) in 34 Congolese Patients. Global Journal of Medical Research. 17, 5 (Mar. 2017), 19–26.